Insmed To Present at Two June Conferences

Rhea-AI Summary

Insmed Incorporated (Nasdaq: INSM), a biopharmaceutical company, announced its management will present at two upcoming virtual investor events: the Jefferies Virtual Healthcare Conference on June 1, 2021, at 9:00 a.m. ET, and the Goldman Sachs 42nd Annual Global Healthcare Conference on June 9, 2021, at 2:10 p.m. ET. Both presentations will be webcast live and archived for 30 days. Insmed focuses on transforming the lives of patients with serious diseases and has a robust pipeline of therapies for unmet medical needs.

BRIDGEWATER, N.J., May 25, 2021 /PRNewswire/ -- Insmed Incorporated Inc. (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the following virtual investor events:

• The Jefferies Virtual Healthcare Conference on June 1, 2021 at 9:00 a.m. ET in a corporate presentation
• The Goldman Sachs 42^nd Annual Global Healthcare Conference on June 9, 2021 at 2:10 p.m. ET in a fireside chat

Each presentation will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Each webcast will be archived for a period of 30 days following the conclusion of each live event.

About Insmed
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing footprint across Europe and in Japan. For more information, visit www.insmed.com.

Contact:

Investors:

Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com

Media:

Mandy Fahey
Senior Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/insmed-to-present-at-two-june-conferences-301298212.html

SOURCE Insmed Incorporated

FAQ

When will Insmed present at the Jefferies Virtual Healthcare Conference?

Insmed will present at the Jefferies Virtual Healthcare Conference on June 1, 2021, at 9:00 a.m. ET.

What time is Insmed's presentation at the Goldman Sachs Global Healthcare Conference?

Insmed's presentation at the Goldman Sachs 42nd Annual Global Healthcare Conference is scheduled for June 9, 2021, at 2:10 p.m. ET.

How can I access Insmed's investor presentations?

Insmed's investor presentations can be accessed live and archived by visiting the investor relations section of their website at www.insmed.com.

What is Insmed's focus in the biopharmaceutical industry?

Insmed focuses on developing therapies for patients with serious and rare diseases, particularly chronic lung diseases and inflammatory conditions.

Where is Insmed Incorporated headquartered?

Insmed Incorporated is headquartered in Bridgewater, New Jersey.